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Abstract
Vescico-Ureteral Reflux (VUR) is a common condition in childhood, caused by a congenital anomaly at the Vescico-
Ureteral Junction (VUJ) level. It seems that the main cause could be an abnormal embryological development
occurred during the early stage of fetal life.
Refluxing ureteral endings show structural and functional anomalies: previous studies have shown a significant
decrease in alfa actin, miosin and desmin contents as well as an high rate of atrophy and muscular degeneration
with disorganized muscular fibres. The roles played by Cajal cells and Connexin 43 in generating peristaltic waves
appears to be fundamental for the physiological VUJ function and activity. Attention was focused also on the
congenital muscular deficiency of the RUs, on regard to general morphology, smooth muscle cells architecture,
inflammatory markers and the distribution of collagen composition.
This review will discuss and investigate the importance of the modified configuration of Sarcoglycan (SG) sub
complex (particularly the deficiency of the ε-SG and the increased expression of the α-SG), the role played by Cajal
Cells, the intravescical tunnel length to ureteral diameter ratio as possible causes of the functional alterations in the
refluxing ureteral ends leading towards the VUJ incompetence.
Keywords: Vesicoureteral reflux, Active antireflux mechanism, Passive antireflux mechansim, Interstitial cells of Cajal,
Sarcoglycan
Background
Primary Vescico-Ureteral Reflux (VUR) is a common
condition likely related to a congenital anomaly of the
Vescico-Ureteral Junction (VUJ) caused by its abnormal
embryological development [1]. VUJ represents the
border-line through the upper urinary tract, character-
ized by low pressure level, and the lower urinary tract,
characterized instead by high pressure [2]. It acts there-
fore, in protecting the upper tract from reflux using both
active and passive anti-reflux mechanisms [2].
The exact incidence of the VUR in the neonatal popu-
lation still remains unknown because of the invasive
radiology required for early diagnosis.
Overall, it is reported to be as low as 1 to 2% but it
might be higher [3].
Data about the incidence of VUR are reported in the
current literature as 25 to 40% of children presenting
with urinary tract infection and in 3 to 19% of infants
with hydronephrosis diagnosed on antenatal ultrasound
scan screening [3].
Passive anti-reflux mechanism
The most common explanation for a competent anti-
reflux mechanism is represented by a passive compres-
sion of the ceiling of the intravesical ureter against the
underlying detrusor, According to this theory, the intra-
vesical length to ureter and its diameter is considered to
be fundamental in maintaining the VUJ closure and pre-
venting VUR.
Specifically, the relationship between the length of the
intravesical ureter and its diameter is reported to be the
tipping point supporting the ‘passive’ reflux defence
mechanism [4].
For this reason, many authors considered the laterality
of the intravesical ostium and the shortness of the ur-
eteric transmural and submucosal course relative to its
diameter as the main cause of VUR [5]. As a conse-
quence, the spontaneous resolution of VUR would be
caused by the bladder growth, thanks to the submucosal
tunnel elongation [5]. However, Oswald et al. [6, 7]
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reported an intravesical length of newborn ureters of
3017.2 ± 388.9 μm and a diameter of 1354.5 ± 231.3 μm,
which implies that the ratio of the intravesical ureteric
length to intravesical ureteric diameter is 2.23 : 1.
Moreover, in fetuses between 11 and 20 weeks of ges-
tation the intravesical ureteric length to diameter ratio
decrease to 0.69:1 and 1.23:1, respectively [7]. This evi-
dence could explain the higher incidence and severity of
VUR in neonates and premature and, also, the tendency
of VUR to solve spontaneously.
Active antireflux mechanism
Because of a lower intravesical ureteric length to diam-
eter ratio than expected, it was suggested that an intrin-
sic event might play a role to impair the so-called “active
antireflux mechanism”.
Active shortening of the longitudinal muscle layer of
the transmural and submucosal ureter areas drive off the
urine bolus into the bladder. Functional and structural
alterations of ureteric ends seem to impair the active
valve mechanism of the VUJ, causing VUR [8, 9].
The smooth muscle cells, therefore act by transform-
ing the extra-cellular matrix (ECM) through the extra-
cellular production of proteinase and their inhibitors [6].
As a consequence, smooth muscular cells could have a
deep impact also in the progression of the maturation
for the refluxing ureters. Evaluating the turn-over of the
ECM, and specifically of collagen I and III, it was re-
ported the role played by the Metalloproinase of the
matrix (MMPs). The MMPs are secreted by connective
cells of mesenchymal origin like fibroblasts, myoblasts
and macrophage CD 68 positive [6]. The abnormal func-
tion of the smooth muscle cells and the alteration of the
micro-environment of the ECM have driven towards the
immunochemical evalutation of S-100 protein as an in-
nervation marker of the ureteral wall.
A study conducted on 36 distal refluxing ureteral ends
(RUs), showed an increased expression of MMP1 in
CD68 cells in the smooth muscle cells and in the fibro-
blasts as well as a significant decrease of the neural cells
S-100 in the positive RUs [6].
The defective innervation of the distal ureteral endings
therefore, could be considered as fundamental for the
modification of the active anti-reflux mechanism.
The regular peristaltic movement is thus essential to
drive the urine bolus from the kidney to the bladder to-
wards the normal peristaltic ureters.
Many authors have reported as dysplasia, atrophy and
architectural derangement of smooth muscle cells in
RUs is essential for the deficient active valve mechanism
[2]. Tokunaka et al. first introduced the term of muscu-
lar dysplasia to describe the anomalies of the intravesci-
cal distal ureteral tract in VUR patients [10].
Reduced smooth muscle fascicles and its defective
configuration, creates an uncoordinated muscular con-
traction accompanied by the loss of c-kit-positive inter-
stitial cells of Cajal (ICCs) at the VUJ level [6, 11, 12].
Such cells were identified by immunostaining for the c-
kit protooncogene at the cell membrane. The ICCs are
cells considered as responsible for pacemaker activity in
the human ureter, and coordinating ureteric motility
[13–15]. These cells produce electrical slow-wave poten-
tial and propagate peristaltic activity. A decrease in ICC
density, is closely associated with a various motility dis-
orders [16, 17], as well known in patients with colonic
slow-transit constipation [18]. Many Authors [11, 12] re-
ported the presence of a few ICCs in patients with VUR.
Their main function is to generate automatic rhythm
for coordinate peristalsis, allowing also anterograde
movement of urine bolus towards the ureters [15, 19].
An inverse correlation has been reported between the
severity of VUR and the loss of ICCs in refluxing ur-
eteric ends [11, 12]. It is not clear why the depletion of
c-kit-expressing ICCs occurs in refluxing ureteric ends.
Interestingly, mammalian ICCs derive from smooth
muscle progenitors, whose differentiation is independent
from neural crest-derived cell lines [20].
In refluxing ureteric ends it has been detected a grade-
correlated defect of muscle cells, among which c-kit-
positive ICCs differentiate inside the ureteric ending, so
that the loss of c-kit-positive ICCs might be a conse-
quence of the disruption of muscle cells. Conversely, as
mesenchymal cells, sorround the mesonephric duct, dif-
ferentiate into the ureteric inner layer of smooth muscle
cells [21], the delayed elongation of the Wolffian duct
endings might be a pathogenetic event for muscular and
subsequent ICC defects in VUR. Thus, the delayed mat-
uration of ureteric ends is coherent with a possible spon-
taneous resolution of VUR, after postnatal remodelling
of the VUJ, as shown for the pathogenesis of primary
megaureter [22].
It has been suggested that the loss of c-kit-positive
ICCs could be also secondary to ureteric trauma during
episodes of VUR, as reported in the proximal segment of
obstructed fetal bowel [23]. Consistently it is acknowl-
edged that the mechanical stress can affect the expres-
sion of developmental genes, providing evidence that
molecular signals are not the only forces involved in
modelling the developing embryo [24]. Moreover, the re-
duction of Connexin 43 has been reported. It is consid-
ered as the most important hexamerous that constitute
the gap junction, essential for the intracellular signal.
The lacking of Connexin 43 might lead to a disfunction
of the smooth muscle cells activity, explaining the ur-
eteral dismotility and the VUR [11].
As regards, manometry on refluxing ureteric showed a
significant decrease in both P max and basal pressure in
Arena et al. Italian Journal of Pediatrics  (2016) 42:103 Page 2 of 5
refluxing ureteral endings, and a highly significant nega-
tive correlation of these values with the grade of VUR.
Moreover in high-grade VUR, RUs showed a severe
impairment of basal pressure and ureteral arrhythmia
and in the worst scenario, a ‘silent’ pressure profile pat-
tern. In fact, in high grade VUR (IV to V) the manom-
etry showed a severe impairment of basal pressure and
ureteral arrhythmia in 73% of RUs, and a “silent” pres-
sure profile pattern in 27% [12].
The variable and inconsistent pressure of the peristal-
tic waves, and its irregular wave rhythm, are likely to re-
sult in disturbed urine transport along the distal part of
RUs. It has been suggested that the silent ureter might
represent an advanced stage of ureteric arrhythmia, sug-
gesting a more damaged ureter that resembles a ureteric
arrhythmic state [11].
The histological and histochemical findings of the RUs
showed a muscular disarrangement and atrophy, and in-
creased interstitial fibrosis, significantly correlated with
the grade of VUR.
Gearhart et al. [25] reported a degree of smooth
muscle deterioration and more collagen deposition in di-
lated ureters with primary VUR. The ureteric refluxing
ends showed a proportion of muscle and collagen de-
creased from normal (1 :0.3) to 1:3 [7]. Furthermore,
Oswald et al. [6] reported a replacement of muscle bun-
dles by connective tissue, leading to ureteric strictness.
It is apparent that any defect of the longitudinal muscle
coat implies an impairment of the active valve mechan-
ism, with subsequent VUR.
Indeed, the impossibility of sufficient contraction of
the ureteric muscular layer produces VUR, by preventing
the closure of the ureteric orifice [5]. The significant im-
pairment of ureteric pressure is obvious, and positively
correlates with the VUR grade. The reduction of basal
pressure is associated with muscle disarrangement or at-
rophy and subsequent interstitial fibrosis in refluxing
ends, leading to loss of muscular mass and ureteric stiff-
ening. Depending on the low density of c-kit-positive
ICCs, shortened irregular (bicuspid) and intermittent
peristaltic waves were recorded, with quiescent periods,
severe impairment of peristalsis, until there was a silent
manometric pattern [12]. It has also been supposed that
an impairment of overall microperfusion in Refluxing
Ureter ends, would lead to tissue ischemia, and dimin-
ished ureteral perfusion are likely to induce and support
smooth muscle cells dysfunction and apoptosis, so as a
result, that functional and structural alterations may fur-
ther deteriorate the active valve mechanism of the ure-
terovesical junction VUJ, causing VUR [5].
Micro vessel density (MVD) is markedly reduced in
the RUs, because of a possible alteration of the blood
stream that is accompanied by a decrease level of Vascu-
lar Endothelial Growth Factor (VEGF), that could
represent the primary cause. The loss of VEGF could
lead to the alteration of the smooth muscle cells and
could play an important role in the reflux mecha-
nisms [8].
Immunohistochemical data and RT PCR study demon-
strated a significant VUR grade relation with the defi-
ciency of ε-SG and with the increased expression of α-
SG [26]. It was supposed that the different behaviour of
SG subunits could be explained in at least 2 ways.
The first hypothesis is that the SG subcomplex could
play a key role in the physiopathology of VUR: the defi-
ciency of any of the SGs would lead to a specific loss of
the SG subcomplex, destabilizing the alfa destroglycan,
and causing the loss of the membrane integrity and fiber
degeneration [27].
Furthermore, this subcomplex is critical for conferring
stability to the muscle membrane, thus, protecting the
sarcolemma from stress that develops during muscle
fiber contraction [28].
The latter hypothesis instead suggest that the struc-
tural deficiency of the trigonal VUJ, could cause a
passive stretching of refluxing urine on the ureter
with derangement of the SG subcomplex. This effect
can also be explained by reduced amplitude of con-
traction and relaxation of the smooth muscle fibers of
the ureter caused by structural deficiency and altered
ureteral peristalsis. This condition could lead to a loss
of mechanical stress transmitted over cell surface re-
ceptors that physically couple the cytoskeleton to the
ECM or to other cells. Therefore, mechanical signals
could be integrated with other environmental signals
and transduced into a biochemical response through
force dependent changes in scaffold geometry or mo-
lecular mechanisms by multimodular tensegrity archi-
tecture [26, 28]. Resultant changes in the topology of
these networks could alter cellular biochemistry dir-
ectly. Consequently, these mechanical changes could
cause modifications of chemical signals, although vari-
ations of the structural pathway of the SG subcom-
plex and α-SG could replace or compensate the loss
of ε-SG.
In fact, an altered configuration of the SG complex,
in particular the deficiency of ε-SG and over expres-
sion of α-SG, could explain the structural and func-
tional changes in RUs, displaying smooth muscle cell
apoptosis, smooth muscular atrophy, increased inter-
stitial fibrosis, hypoperistaltic or ureteroarrhythmic
manometric pattern and, at least, the impaired overall
microperfusion, diminishing the active valve mechan-
ism of the VUJ.
The altered expression of SGs, causing a structural in-
stability to the muscular plasmatic membrane might
promote stress damage that develops during smooth
muscle fiber contraction in RUs, loss of membrane
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integrity, smooth muscle cell apoptosis and fiber
degeneration.
Moreover, the loss of ε-SG could explain the mano-
metric findings in the VUJ of RUs, including hypoperis-
talsis and ureteroarrhythmia or “silent” pattern [26].
It is noteworthy that the depletion of c-kit positive
ICCs in RUs might be the consequence of the disruption
of smooth muscle cells, progenitors of ICCs, or second-
ary to mechanical stress, affecting the expression of de-
velopmental genes, during episodes of VUR [12, 26].
Moreover, loss of ε-SG in RUs might explain the over-
all microperfusion, ongoing functional and structural al-
terations of vesicoureteral junction, and subsequent
deterioration of the active antireflux mechanism [26].
Conclusion
The pathogenesis of primary VUR still remains unclear.
It seems that a possible mechanism on its develop-
ment could be research during the early embryonic
phase.
The most important anomaly seems to occurred at the
VUJ level.
Several studies have shown how the reduction of
smooth muscle fascicles and the defective configuration
at VUJ level, creates an uncoordinated muscular con-
traction also accompanied by the loss of c-kit-positive
ICCs.
The role of ICCs, infact should be related to the main-
tainance of normal peristaltic waves driving the urine
bolus towards an anterograde way.
Focusing on the smooth muscle cells of the VUJ, the
action of some drugs as alpha-blockers or anticholiner-
gics could results in beneficial effects in the treatment of
VUR associated to dysfunctional voiding [29, 30].
Changes at ECM have been widely discussed and re-
ported in the current literature, and it seems that an im-
portant role is played by the modification of sarcoglicans
especially in the development of distal tract of refluxing
ureters.
Further studies are needed in order to have a better
understanding of the antireflux mechanisms.
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